New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 10, 2013
21:17 EDTMMM, NEOG, IDXX, ECL, CRL, BASI, PRXL, CVDChina government overhaul includes food and drug safety, WSJ says
China plans to overhaul government agencies including the organizations that oversee its one-child policy and its food and drug safety, says the Wall Street Journal. Reference Link
News For MMM;NEOG;IDXX;ECL;CRL;BASI;PRXL;CVD From The Last 14 Days
Check below for free stories on MMM;NEOG;IDXX;ECL;CRL;BASI;PRXL;CVD the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
July 25, 2014
07:06 EDTIDXXIDEXX sees FY15 organic revenue growth of 9%-10%
Operating margins, excluding previously described transitional impacts in both 2014 and 2015, are expected to be relatively flat next year.
07:05 EDTIDXXIDEXX backs FY14 adjusted EPS $3.79-$3.86, consensus $3.84
Sees FY14 revenue $1.51B-$1.52B, consensus $1.5B; Sees FY14 free cash flow is 95%-100% of net income; Sees FY14 CapEx $80M.
07:04 EDTIDXXIDEXX says all-direct distribution model to capture $50M-$55M in additional reve
Subscribe for More Information
07:02 EDTIDXXIDEXX board authorized repurchase of up to an addition 5M shares of common stock
Subscribe for More Information
07:02 EDTIDXXIDEXX plans to move from hybrid to all-direct product distribution model in 2015
The comapny said, "Under this approach, we intend to take orders, ship product, invoice and receive payment, and recognize revenue for all rapid assay test kits and instrument consumables in the US, aligning with our direct model for instruments, reference lab services, and other CAG products and services... The change to an all-direct product distribution approach will allow a significant expansion in our direct sales coverage and capacity, including an estimated 40% increase in the Veterinary Diagnostic Consultant field sales role and a 60% increase in customer field call frequency. With this increase, we will be much better equipped to support our US veterinary customers' growth in the use of IDEXX diagnostics to provide the best medical care for their patients and clients. The change will result in an incremental annual $50 million to $55 million, or 5%, increase in our fast growing recurring diagnostic revenue, with accretive profit benefits that will scale over time, following the transition to the new model."
07:01 EDTIDXXIDEXX reports Q2 EPS $1.10, consensus $1.06
Subscribe for More Information
July 24, 2014
09:25 EDTMMM3M Company sees FY gross share repurchases $4.5B-$5B
Previously expected $4B-$5B in gross share repurchases. Sees FY CapEx $1.5B-$1.6B. Comments made on the Q2 earnings conference call.
08:51 EDTNEOGNeogen commented on potential revenue from rodenticide research
Subscribe for More Information
08:21 EDTMMM3M Company sees Sumitomo 3M deal closing September 1
Subscribe for More Information
07:34 EDTMMM3M Company reaffirms 2014 EPS outlook $7.30-$7.55, consensus $7.47
Subscribe for More Information
07:33 EDTMMM3M Company reports Q2 EPS $1.91, consensus $1.91
Subscribe for More Information
July 23, 2014
15:30 EDTMMMNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include Ford (F), consensus 36c; General Motors (GM), consensus 58c; Potash (POT), consensus 46c; Caterpillar (CAT), consensus $1.52; 3M (MMM), consensus $1.91; Union Pacific (UNP), consensus $1.43; Bristol-Myers Squibb (BMY), consensus 44c; Eli Lilly (LLY), consensus 65c; Celgene (CELG), consensus 89c; Precision Castparts (PCP), consensus $3.35; Raytheon (RTN), consensus $1.59; Noble Energy (NBL), consensus 79c; Hershey (HSY), consensus 76c; Southwest Airlines (LUV), consensus 61c; Boston Scientific (BSX), consensus 19c; JetBlue (JBLU), consensus 19c.
10:02 EDTNEOGOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:15 EDTNEOGNeogen upgraded to Overweight from Equal Weight at Stephens
Subscribe for More Information
07:57 EDTNEOGNeogen upgraded to Buy from Hold at Craig-Hallum
Price target raised to $55 from $44.
July 22, 2014
13:10 EDTMMM3M Company July weekly volatility elevated into Q2 and outlook
Subscribe for More Information
08:48 EDTNEOGNeogen reports Q4 EPS 20c, consensus 21c
Subscribe for More Information
07:08 EDTIDXXLife Sciences highlights this week at Canaccord
Canaccord highlighted six diagnostic names that report this week and recommends buying Top Pick IDEXX (IDXX) into the print given strong recurring razor/razorblade sales and consistent organic growth. The analyst expects Hold rated Quest Diagnostics (DGX) to report upside to Street estimates of $1.06/$1.882B, Quidel (QDEL) to have an uneventful report, Exact Sciences (EXAS) to provide an update on numerous catalysts near-term and Abaxis (ABAX) to report earnings below consensus. Lastly, the firm is cautious on Meridian Bioscience (VIVO) following a competitor report last week.
July 18, 2014
16:33 EDTNEOGNeogen COO resigns
Subscribe for More Information
July 16, 2014
05:33 EDTMMM3M to acquire Sumitomo Electric interest in Sumitomo 3M for $885M
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use